News Detail
New Delhi, 16 July 2024: The Supreme Court on Monday upheld the National Pharmaceutical Pricing Authority’s (NPPA) decision to recover Rs 4.65 crore including interest towards excess price charged by Sun Pharmaceuticals for Roscilox, a brand of a Cloxacillin-based drug form......
View Details
Source : Economic Times
Sun Pharma news
Supreme Court
Sun Pharma
Sun Pharma latest
Sun Pharma latest news
excess price charged
National Pharmaceutical Pricing Authority
DPCO
Roscilox
Related News
- Two Individuals Arrested with 2,450 Intoxicating Tablets; FIR Filed (17-03-2025)
- MIT engineers turn skin cells directly into neurons for cell therapy (17-03-2025)
- Police bust illegal sale of expired govt drugs in Kampala, 10 arrested (17-03-2025)
- Sun and Zydus Pharma pulling back some medications in the US due to quality issues (17-03-2025)
- Two Smugglers arrested with 11,520 Illegal Tablets (17-03-2025)
- Huge Stock of illegal cough syrups confiscated, two arrested (17-03-2025)
- Par panel suggests single independent drug controller for AYUSH (17-03-2025)
- Rise in pediatric pneumonia cases underscores the increasing issue of antibiotic resistance (16-03-2025)
- Extended use of steroids linked to risk of glaucoma, AIIMS docs caution (16-03-2025)
- Indian pharma increasing acquisitions in US amid regulatory and market shifts (16-03-2025)